Top 25 Companies in Global Cardiac Ablation Market: Global Share, Market Size, Revenue Report (2026–2035)

According to a research report published by Spherical Insights & Consulting, the Global Cardiac Ablation Market Size is projected to grow from USD 5.73 billion in 2025 to USD 19.69 billion by 2035, at a CAGR of 13.14% during the forecast period 2026–2035. Rising prevalence of cardiac arrhythmias, increasing geriatric population, growing adoption of minimally invasive procedures, technological advancements in ablation devices, improving healthcare infrastructure, and supportive government initiatives are driving cardiac ablation market growth.

 

Introduction

The cardiac ablation market can be defined as the industry that deals with ablation devices and procedures performed using energy sources such as radiofrequency energy, cryoablation, and pulsed fields to destroy abnormal tissues in the heart. This industry is growing rapidly because of the increase in the occurrence of heart problems and the need for less invasive methods. The raw materials involved are usually advanced polymers, metals, electrodes, and other elements needed in making cardiac ablation devices. Some of the major drivers are the rise in the prevalence of atrial fibrillation, aging populations, and improvements in the efficiency and safety of the procedures. The applications for cardiac ablation devices are found mainly in hospitals where they can be used in the treatment of atrial fibrillation, tachycardia, and other arrhythmias. The government efforts to improve cardiovascular disease management programs and healthcare infrastructures have also contributed to the growth of this market. By November 2025, there has been considerable use of pulsed field ablation technology worldwide, with significant improvement in both patient outcomes and procedure speed. Recent technological innovations include robotic assistance systems and artificial intelligence-based cardiac mapping technology.

 

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

In February 2026, global medical device company Medtronic reported strong growth in its cardiac ablation segment, with pulsed field ablation device sales increasing significantly, highlighting rising global demand for advanced minimally invasive cardiac treatments.

In February 2026, Medtronic announced the acquisition of CathWorks to expand its cardiovascular and ablation-related technology portfolio, strengthening its position in advanced cardiac diagnostics and treatment solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Cardiac Ablation Market.

 

Market Segmentation

Global Cardiac Ablation Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Radiofrequency Ablation, Cryoablation, Pulsed Field Ablation, Laser Ablation, Microwave Ablation), By Application (Atrial Fibrillation, Ventricular Tachycardia, Supraventricular Tachycardia, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Cardiac Centers), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 2026–2035.

 

Cardiac Ablation Market Size & Statistics

• The Market Size for Cardiac Ablation Was Estimated to be worth USD 5.73 Billion in 2025.
• The Market is Going to Expand at a CAGR of 13.14% between 2026 and 2035.
• The Global Cardiac Ablation Market Size is anticipated to reach USD 19.69 Billion by 2035.
• Asia Pacific is expected to grow the fastest during the forecast period in the Cardiac Ablation Market.
• North America is expected to generate the highest demand during the forecast period in the Cardiac Ablation market.

Regional growth and demand

                                  

Asia Pacific is expected to grow the fastest during the forecast period in the Cardiac Ablation market. The region’s rapid expansion is driven by the increasing prevalence of cardiovascular diseases, rising geriatric population, and improving healthcare infrastructure across countries such as China, India, and Japan. Growing awareness about minimally invasive procedures and expanding access to advanced cardiac care in emerging economies are accelerating market growth. Government initiatives focusing on strengthening healthcare systems, increasing investments in cardiac care facilities, and promoting early diagnosis and treatment of arrhythmias are further boosting demand. Additionally, the presence of a large patient pool and rising adoption of advanced technologies such as pulsed field ablation contribute significantly to regional growth.

 

North America is expected to generate the highest demand during the forecast period in the Cardiac Ablation market. This demand is driven by a high prevalence of atrial fibrillation and other cardiac arrhythmias, well-established healthcare infrastructure, and early adoption of advanced medical technologies. The region benefits from strong reimbursement policies, continuous technological innovations, and the presence of leading market players. Increasing investments in research and development, along with favorable government support for advanced treatment procedures, further enhance market demand. Moreover, the growing preference for minimally invasive procedures and increasing use of AI-integrated and robotic-assisted ablation systems contribute to sustained growth in North America.

 

 

Top 10 Trends in the Cardiac Ablation Market

• Rising adoption of minimally invasive cardiac procedures
• Growing use of pulsed field ablation technology
• Increasing prevalence of atrial fibrillation worldwide
• Integration of AI in cardiac mapping and diagnostics
• Advancements in catheter design and navigation systems
• Expansion of outpatient and ambulatory surgical centers
• Increasing geriatric population and cardiac disorders
• Growing demand for safer and faster ablation procedures
• Strategic collaborations and product innovations by key players
• Rising healthcare investments in cardiovascular treatment

 

Top 5 Trends

1. Rising Adoption of Minimally Invasive Procedures

Minimally invasive cardiac ablation procedures are gaining strong traction due to reduced recovery time, lower risk of complications, and shorter hospital stays. Patients and healthcare providers increasingly prefer catheter-based ablation over traditional surgical approaches, as it offers improved safety and efficiency. Hospitals are also promoting these procedures to reduce healthcare costs and optimize patient throughput. The trend is further supported by advancements in imaging and navigation technologies that enhance procedural precision. As awareness increases and healthcare infrastructure improves, especially in emerging markets, the demand for minimally invasive cardiac ablation procedures is expected to continue rising significantly over the forecast period.

 

2. Growing Use of Pulsed Field Ablation Technology

Pulsed field ablation (PFA) is emerging as a breakthrough technology in the cardiac ablation market due to its ability to selectively target cardiac tissue while minimizing damage to surrounding structures. Unlike traditional thermal ablation methods, PFA uses electric fields, offering improved safety and reduced procedural complications. This technology is gaining rapid adoption in treating atrial fibrillation, as it enhances efficiency and shortens procedure time. Medical device companies are increasingly investing in PFA research and commercialization, driving innovation. As clinical evidence continues to support its benefits, pulsed field ablation is expected to become a standard treatment approach in the coming years.

 

3. Increasing Prevalence of Atrial Fibrillation Worldwide

The rising global incidence of atrial fibrillation is a major factor influencing trends in the cardiac ablation market. Sedentary lifestyles, aging populations, and increasing cases of obesity and hypertension are contributing to the growing burden of cardiac arrhythmias. As atrial fibrillation significantly increases the risk of stroke and heart failure, there is a rising demand for effective treatment options such as ablation procedures. Healthcare systems are focusing on early diagnosis and management of arrhythmias, further boosting procedure volumes. This trend is particularly strong in developed regions but is also rapidly emerging in developing economies due to improving healthcare access.

 

4. Integration of AI in Cardiac Mapping and Diagnostics

Artificial intelligence is transforming cardiac ablation procedures by enhancing mapping accuracy and improving clinical decision-making. AI-powered mapping systems help physicians identify abnormal electrical pathways more precisely, leading to higher success rates and reduced recurrence of arrhythmias. These technologies also assist in real-time data analysis during procedures, improving efficiency and patient outcomes. The integration of AI with imaging and navigation systems is enabling more personalized treatment planning. As digital healthcare adoption increases and hospitals invest in smart technologies, AI-driven cardiac ablation solutions are expected to play a crucial role in advancing the market.

 

5. Advancements in Catheter Design and Navigation Systems

Technological advancements in catheter design and navigation systems are significantly improving the effectiveness of cardiac ablation procedures. Modern catheters offer enhanced flexibility, better contact force sensing, and improved energy delivery, enabling more precise targeting of abnormal tissues. Navigation systems integrated with 3D mapping technologies provide real-time visualization, allowing physicians to perform complex procedures with greater accuracy. These innovations reduce procedure time, enhance safety, and improve overall success rates. Continuous research and development by medical device manufacturers are leading to the introduction of next-generation ablation tools, which are expected to further drive market growth and adoption globally.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Cardiac Ablation market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 25 Companies Leading the Cardiac Ablation Market

1. Medtronic plc
2. Abbott Laboratories
3. Boston Scientific Corporation
4. Johnson & Johnson (Biosense Webster)
5. Siemens Healthineers AG
6. Koninklijke Philips N.V.
7. GE HealthCare Technologies Inc.
8. Biotronik SE & Co. KG
9. MicroPort Scientific Corporation
10. Stereotaxis Inc.
11. AtriCure Inc.
12. LivaNova PLC
13. Japan Lifeline Co., Ltd.
14. Merit Medical Systems, Inc.
15. AngioDynamics, Inc.
16. Acutus Medical, Inc.
17. CardioFocus, Inc.
18. Baylis Medical Company Inc.
19. Osypka AG
20. Imricor Medical Systems, Inc.
21. CathVision ApS
22. Kardium Inc.
23. Ablacon, Inc.
24. Adagio Medical, Inc.
25. HexaCath

 

1. Medtronic plc

Headquarters: Dublin, Ireland

Medtronic plc is a global leader in medical technology and one of the dominant players in the cardiac ablation market, offering a wide range of radiofrequency and cryoablation systems along with advanced catheter solutions. The company is at the forefront of innovation with its pulsed field ablation technologies, designed to improve procedural safety and efficiency in treating atrial fibrillation. Medtronic focuses heavily on research and development, integrating advanced mapping systems and minimally invasive solutions into its product portfolio. With a strong global presence and strategic partnerships with healthcare providers, the company plays a critical role in advancing cardiac rhythm management and expanding access to effective ablation therapies worldwide.

 

2. Abbott Laboratories

Headquarters: Illinois, United States

Abbott Laboratories is a key player in the cardiac ablation market, known for its advanced electrophysiology portfolio that includes mapping systems, diagnostic catheters, and ablation technologies. The company emphasizes precision medicine through innovative solutions that enhance real-time cardiac mapping and improve procedural outcomes. Abbott’s EnSite mapping platform is widely used to guide ablation procedures with high accuracy. Its strong focus on technological innovation, combined with a global distribution network, enables the company to support a broad range of cardiac care applications. Abbott continues to invest in next-generation ablation technologies to address the growing global burden of cardiac arrhythmias.

 

3. Boston Scientific Corporation

Headquarters: Massachusetts, United States

Boston Scientific Corporation is a leading developer of medical devices with a strong presence in the cardiac ablation market, particularly in electrophysiology and atrial fibrillation treatment solutions. The company offers advanced ablation catheters, mapping systems, and imaging technologies that enhance procedural precision and safety. Boston Scientific focuses on continuous innovation and clinical research to improve patient outcomes and expand its product capabilities. Its strategic acquisitions and investments in next-generation ablation technologies strengthen its competitive position. With a well-established global footprint, the company supports hospitals and cardiac centers in delivering effective and minimally invasive arrhythmia treatments.

 

4. Johnson & Johnson (Biosense Webster)

Headquarters: California, United States

Johnson & Johnson, through its subsidiary Biosense Webster, is a pioneer in the field of cardiac electrophysiology and ablation technologies. The company provides advanced 3D mapping systems, ablation catheters, and visualization tools that enable precise diagnosis and treatment of complex arrhythmias. Biosense Webster is widely recognized for its CARTO mapping system, which enhances procedural accuracy and efficiency. The company continuously invests in research and innovation, focusing on improving patient safety and clinical outcomes. Its strong presence in global healthcare markets and collaboration with medical professionals contribute to the widespread adoption of its advanced ablation solutions.

 

5. Siemens Healthineers AG

Headquarters: Erlangen, Germany

Siemens Healthineers AG plays a significant role in the cardiac ablation market by providing advanced imaging and diagnostic systems that support electrophysiology procedures. The company’s solutions include high-resolution imaging technologies and integrated software platforms that enhance visualization and guidance during ablation procedures. Siemens Healthineers focuses on digital health innovation, combining imaging with AI-powered analytics to improve treatment planning and procedural accuracy. Its strong emphasis on technological advancement and healthcare digitalization enables better clinical decision-making. With a global presence and strong partnerships with healthcare institutions, the company contributes to improving the efficiency and effectiveness of cardiac ablation therapies.

 

Are you ready to discover more about the Cardiac Ablation market?

The report provides an in-depth analysis of the leading companies operating in the global Cardiac Ablation market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Medtronic plc

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

 

1. Abbott Laboratories
2. Boston Scientific Corporation
3. Johnson & Johnson (Biosense Webster)
4. Siemens Healthineers AG
5. Koninklijke Philips N.V.
6. GE HealthCare Technologies Inc.
7. Biotronik SE & Co. KG
8. MicroPort Scientific Corporation
9. Others.

 

Conclusion

The cardiac ablation market is experiencing strong growth driven by the rising global burden of cardiac arrhythmias, increasing adoption of minimally invasive procedures, and continuous technological advancements in ablation systems. The market is benefiting from innovations such as pulsed field ablation, AI-based mapping, and advanced catheter designs that enhance procedural precision and patient outcomes. Growing healthcare investments, supportive government initiatives, and expanding access to cardiac care, particularly in emerging economies, are further accelerating market expansion. Additionally, the presence of leading medical device companies focusing on research, strategic collaborations, and product development strengthens the competitive landscape. As demand for safer, faster, and more effective treatment options continues to rise, the cardiac ablation market is expected to witness sustained growth and play a crucial role in modern cardiovascular treatment globally during the forecast period 2026–2035.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter